{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:31:41Z","timestamp":1786422701498,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022230","name":"Princess Nourah bint Abdulrahman University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["PNURSP2026R854"],"award-info":[{"award-number":["PNURSP2026R854"]}],"id":[{"id":"10.13039\/501100022230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cca.2026.121112","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:33:36Z","timestamp":1779582816000},"page":"121112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Circulating CHI3L1\/YKL-40 in lung cancer: Biomarker potential, analytical challenges, and clinical translation prospects"],"prefix":"10.1016","volume":"591","author":[{"given":"Asma B.","family":"Omer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakir","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqaiyah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121112_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cca.2026.121112_bb0010","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/cncr.35128","article-title":"Lung cancer statistics, 2023","volume":"130","author":"Kratzer","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2026.121112_bb0015","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/CM9.0000000000002529","article-title":"Global burden and trends of lung cancer incidence and mortality","volume":"136","author":"Li","year":"2023","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.cca.2026.121112_bb0020","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/labmed\/lmac122","article-title":"Association of CEA, NSE, CYFRA 21-1, SCC-ag, and ProGRP with clinicopathological characteristics and chemotherapeutic outcomes of lung Cancer","volume":"54","author":"Bi","year":"2023","journal-title":"Lab. Med."},{"key":"10.1016\/j.cca.2026.121112_bb0025","first-page":"286","article-title":"Clinical utility of serum tumor markers in lung cancer","volume":"14","author":"Xiao","year":"2011","journal-title":"Chin. J. Lung Cancer"},{"key":"10.1016\/j.cca.2026.121112_bb0030","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.62347\/TAEI9443","article-title":"Diagnostic efficiency of peripheral tumor serum biomarkers in lung cancer and their correlation with clinicopathological features","volume":"17","author":"Lv","year":"2025","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.cca.2026.121112_bb0035","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2025.010702","article-title":"Serum progastrin-releasing peptide in pneumonia, chronic obstructive pulmonary disease and early-stage primary lung cancers","volume":"35","author":"Begolli","year":"2025","journal-title":"Biochem. Med. (Zagreb)"},{"key":"10.1016\/j.cca.2026.121112_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ph17030307","article-title":"The role of Chitinase-3-like Protein-1 (YKL40) in the therapy of Cancer and other chronic-inflammation-related diseases","volume":"17","author":"Chang","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.cca.2026.121112_bb0045","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1189\/jlb.3VMR0415-142R","article-title":"YKL-40\/CHI3L1 drives inflammation on the road of tumor progression","volume":"98","author":"Libreros","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cca.2026.121112_bb0050","first-page":"287","article-title":"Chitinase-3-like-1\/YKL-40 as marker of circulating tumor cells","volume":"4","author":"Hamilton","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.cca.2026.121112_bb0055","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/cancers2031453","article-title":"YKL-40-a protein in the field of translational medicine: a role as a biomarker in Cancer patients?","volume":"2","author":"Schultz","year":"2010","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121112_bb0060","doi-asserted-by":"crossref","DOI":"10.36922\/arnm.4173","article-title":"Advances in molecular imaging for early detection of lung cancer","volume":"2","author":"Li","year":"2024","journal-title":"ARNM"},{"key":"10.1016\/j.cca.2026.121112_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2024.130706","article-title":"COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma","volume":"1868","author":"Wu","year":"2024","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.cca.2026.121112_bb0070","article-title":"YKL-40 as a biomarker in various inflammatory diseases: a review","volume":"34","author":"Blazevic","year":"2024","journal-title":"Biochem. Med. (Zagreb)"},{"key":"10.1016\/j.cca.2026.121112_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/cells14130982","article-title":"Future perspectives and conclusions from animal models of CHI3L1-related inflammation-associated Cancer","volume":"14","author":"Mizoguchi","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.cca.2026.121112_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-023-01131-9","article-title":"Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer","volume":"56","author":"Yu","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"1\u20133","key":"10.1016\/j.cca.2026.121112_bb0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12026-013-8459-y","article-title":"CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory\/pro-tumorigenic and angiogenic factors","volume":"57","author":"Libreros","year":"2013","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cca.2026.121112_bb0090","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00018-018-2997-3","article-title":"Tumor-associated macrophages: a short compendium","volume":"76","author":"Prenen","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cca.2026.121112_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.lungcan.2004.11.011","article-title":"Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer","volume":"48","author":"Junker","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cca.2026.121112_bb0100","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1878-0261.13152","article-title":"Anti-Chi3L1 antibody suppresses lung tumor growth and metastasis through inhibition of M2 polarization","volume":"16","author":"Yu","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cca.2026.121112_bb0105","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s13277-014-2690-6","article-title":"Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2026.121112_bb0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7150\/thno.65522","article-title":"Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.cca.2026.121112_bb0115","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00262-019-02344-6","article-title":"Novel circulating tumor cell-based blood test for the assessment of PD-L1 protein expression in treatment-na\u00efve, newly diagnosed patients with non-small cell lung cancer","volume":"68","author":"Chen","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cca.2026.121112_bb0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000438643","article-title":"Elevated serum concentration of chitinase 3-like 1 is an independent prognostic biomarker for poor survival in lung Cancer patients","volume":"38","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cca.2026.121112_bb0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/1055-9965.EPI-05-0011","article-title":"Serum YKL-40, a new prognostic biomarker in cancer patients?","volume":"15","author":"Johansen","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cca.2026.121112_bb0130","article-title":"Stat3 downstream gene product chitinase 3-like 1 is a potential biomarker of inflammation-induced lung cancer in multiple mouse lung tumor models and humans","volume":"8","author":"Yan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2026.121112_bb0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-020-00303-7","article-title":"Chitinase-3 like-protein-1 function and its role in diseases","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cca.2026.121112_bb0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12964-019-0503-7","article-title":"Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis","volume":"18","author":"Park","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.cca.2026.121112_bb0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12964-025-02601-5","article-title":"CHI3L1 promotes cell division through activation of RhoA in lung cancer cells","volume":"24","author":"Yu","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.cca.2026.121112_bb0150","doi-asserted-by":"crossref","first-page":"9964","DOI":"10.1038\/s41598-023-36844-4","article-title":"CHI3L1 induces autophagy through the JNK pathway in lung cancer cells","volume":"13","author":"Hong","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.121112_bb0155","article-title":"Inhibition of Chitinase-3-like protein 1 reduced epithelial-mesenchymal transition and vascular epithelial cadherin expression in oesophageal squamous cell carcinoma","volume":"22","author":"Qin","year":"2024","journal-title":"Iran. J. Biotechnol."},{"key":"10.1016\/j.cca.2026.121112_bb0160","article-title":"Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer","volume":"60","author":"Watanabe","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cca.2026.121112_bb0165","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137750","article-title":"CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses","volume":"131","author":"Ma","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2026.121112_bb0170","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202403138","article-title":"Up-regulated chitinase-like protein-1 promotes tumour growth while physiological levels are protective","volume":"8","author":"Yan","year":"2025","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.cca.2026.121112_bb0175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.lungcan.2004.05.010","article-title":"High serum YKL-40 level in patients with small cell lung cancer is related to early death","volume":"46","author":"Johansen","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cca.2026.121112_bb0180","article-title":"Serum YKL-40 level is associated with the chemotherapy response and prognosis of patients with small cell lung cancer","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2026.121112_bb0185","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/0959-8049(95)00196-P","article-title":"Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer","volume":"31a","author":"Johansen","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cca.2026.121112_bb0190","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1002\/cncr.25196","article-title":"Elevated pretreatment serum concentration of YKL-40-an independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer","volume":"116","author":"Th\u00f6m","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2026.121112_bb0195","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/02841861003631503","article-title":"High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer","volume":"49","author":"Choi","year":"2010","journal-title":"Acta Oncol."},{"key":"10.1016\/j.cca.2026.121112_bb0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5578\/tt.67319","article-title":"High serum YKL-40 level is associated with poor prognosis in patients with lung cancer","volume":"66","author":"\u00c7ileda\u011f","year":"2018","journal-title":"Tuberk. Toraks"},{"key":"10.1016\/j.cca.2026.121112_bb0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5578\/tt.8390","article-title":"The place of YKL-40 in non-small cell lung cancer","volume":"62","author":"K\u0131rankaya G\u00fcne\u015f","year":"2014","journal-title":"Tuberk. Toraks"},{"key":"10.1016\/j.cca.2026.121112_bb0210","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.freeradbiomed.2026.05.288","article-title":"Carbon ions collapse the hypoxic lipid shield to decouple survival from redox vulnerability in NSCLC","volume":"252","author":"Ma","year":"2026","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cca.2026.121112_bb0215","doi-asserted-by":"crossref","first-page":"27087","DOI":"10.1038\/s41598-025-11537-2","article-title":"Circulating CHI3L1 autoantibodies serve as a diagnostic biomarker in patients with obstructive sleep apnea","volume":"15","author":"Hao","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.121112_bb0220","doi-asserted-by":"crossref","first-page":"39740","DOI":"10.18632\/oncotarget.5469","article-title":"Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma","volume":"6","author":"Chiang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cca.2026.121112_bb0225","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12935-019-0983-y","article-title":"Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies","volume":"19","author":"Bian","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cca.2026.121112_bb0230","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000330840","article-title":"Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease","volume":"83","author":"Otsuka","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.cca.2026.121112_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106344","article-title":"CircSETD3 mediates acquired resistance to gefitinib in non-small lung cancer cells by FXR1\/ECT2 pathway","volume":"154","author":"Wen","year":"2023","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cca.2026.121112_bb0240","doi-asserted-by":"crossref","first-page":"1228907","DOI":"10.3389\/fimmu.2023.1228907","article-title":"Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy","volume":"14","author":"Johansen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121112_bb0245","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.3233\/TUB-230021","article-title":"Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations","volume":"46","author":"Trulson","year":"2024","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2026.121112_bb0250","article-title":"Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer","volume":"38","author":"de Jager","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.cca.2026.121112_bb0255","first-page":"492","article-title":"Evaluation of the relationship between YKL-40 level and clinical severity in patients with Crimean-Congo hemorrhagic fever, Pathog glob","volume":"118","author":"Aydin","year":"2024","journal-title":"Health"},{"key":"10.1016\/j.cca.2026.121112_bb0260","article-title":"Impact of preanalytical factors on blood CHI3L1 levels","volume":"16","author":"Comabella","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121112_bb0265","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/00365510050184886","article-title":"Stability of YKL-40 concentration in blood samples","volume":"60","author":"H\u00f8gdall","year":"2000","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"9\u201310","key":"10.1016\/j.cca.2026.121112_bb0270","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cca.2011.01.022","article-title":"Plasma YKL-40 levels in healthy subjects from the general population","volume":"412","author":"Bojesen","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121112_bb0275","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/rheumatology\/35.6.553","article-title":"Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint","volume":"35","author":"Johansen","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.cca.2026.121112_bb0280","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2466-13-77","article-title":"Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease","volume":"13","author":"Holmgaard","year":"2013","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.cca.2026.121112_bb0285","doi-asserted-by":"crossref","DOI":"10.4110\/in.2024.24.e3","article-title":"Cigarette smoke extract-treated mouse airway epithelial cells-derived Exosomal LncRNA MEG3 promotes M1 macrophage polarization and Pyroptosis in chronic obstructive pulmonary disease by upregulating TREM-1 via m6A methylation","volume":"24","author":"Wang","year":"2024","journal-title":"Immune Netw."},{"key":"10.1016\/j.cca.2026.121112_bb0290","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.rmed.2013.07.013","article-title":"The relation of circulating YKL-40 to levels and decline of lung function in adult life","volume":"107","author":"Guerra","year":"2013","journal-title":"Respir. Med."},{"key":"10.1016\/j.cca.2026.121112_bb0295","doi-asserted-by":"crossref","first-page":"25117","DOI":"10.3402\/ecrj.v2.25117","article-title":"YKL-40 and genetic status of CHI3L1 in a large group of asthmatics","volume":"2","author":"Hansen","year":"2015","journal-title":"Eur. Clin. Respir. J."},{"key":"10.1016\/j.cca.2026.121112_bb0300","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.e20622","article-title":"Chitinase 3-like-1 (CHI3L1): a potential prognostic biomarker for immunotherapy (IO) in non-small cell lung cancer (NSCLC)","volume":"43","author":"Khan","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cca.2026.121112_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102108","article-title":"Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancer","volume":"49","author":"Kamle","year":"2024","journal-title":"Transl. Oncol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:20:17Z","timestamp":1786422017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126002949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":61,"alternative-id":["S0009898126002949"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121112","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating CHI3L1\/YKL-40 in lung cancer: Biomarker potential, analytical challenges, and clinical translation prospects","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121112"}}